Delivery Order SPE2DB24D3014-SPE2DB24FKSJG

Award Date 9/28/24
Potential Completion Date 9/30/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,480.32 firm fixed-price contract is for the supply of Protopam Chloride 1 GM vials, a medication used to treat certain medical conditions. The contract has a completion date of June 3, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,870.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Protopam Chloride 1 GM vials, a medical product, with a period of performance through January 6, 2025. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This is a Firm Fixed Price delivery order contract (SPE2DB22D1057|SPE2DB24FSJR7) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Protopam Chloride 1 GM vials. The contract has a ceiling value of $1,027.56 and a completion date of August 26, 2024. It is not set aside. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical commodities to various federal agencies and healthcare programs through its extensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROTOPAM CHLORIDE 1 GM VIALS, with a ceiling value of $4,292.95 and a period of performance through June 18, 2025. The contract is not set aside and was awarded on June 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of PROTOPAM CHLORIDE 1 GM VIALS. The contract has a ceiling value of $1,814.95 and a period of performance through July 2, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROTOPAM CHLORIDE 1 GM VIALS, a pharmaceutical product, with a ceiling value of $1,149.24 and a period of performance through May 13, 2025. The contract is a firm fixed-price delivery order, meaning Amerisourcebergen will provide the specified quantity of the product at a...
This is a federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, with a ceiling value of $1,525.55, is a Delivery Order for the supply of PROTOPAM CHLORIDE 1 GM VIALS to the Department of Defense's Medical Supply Chain. The contract has no set-aside designation and was awarded on a full and open competition basis. AmerisourceBergen, a subsidiary of...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of PROTOPAM CHLORIDE 1 GM VIALS, a pharmaceutical product, with a ceiling value of $4,222.88 and a completion date of June 10, 2025. The contract is a Firm Fixed Price (FFP) arrangement and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Provocholine 100 mg vials, a medical product used for various medical purposes. The contract has a ceiling value of $13,851.95 and is a Firm Fixed Price Delivery Order contract with a completion date of June 5, 2024. The contract is not designated as a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,846,728 units of Provocholine inhalation solution. The $1,602.39 firm fixed-price contract has a period of performance through September 18, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 for delivering a comprehensive range of medical commodities to...
  • SPE2DB24D3014
    Indefinite Delivery Contract
  • SPE2DB24D3014-SPE2DB24FKSJG
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Protopam Chloride 1 GM vials. The order has a ceiling value of $1,159.44 and is a firm fixed-price contract. The period of performance extends through September 30, 2024. The award is not associated with a set-aside program. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medications and medical supplies to support military treatment facilities, veterans' hospitals, and other government healthcare programs. In addition to this specific delivery order, the company holds several Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice, valued up to $999,999,999 and $750,000 respectively, to deliver a comprehensive portfolio of pharmaceutical and medical commodities.

Generated 12/28/24, 9:10 AM